Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial

作者：Dan-Yun Ruan, Furong Liu, Xiao-Li Wei, Su-Xia Luo, Zhixiang Zhuang, Zhen-Ning Wang, Funan Liu, Yanqiao Zhang, Jianwei Yang, Zhendong Chen, Yongsheng Wang, Junye Wang, Xiaohua Liang, Xiaojie Wu, Yulong Zheng, Jian Li, Xi Shi, Rakesh Kumar, Wei Liu, Chen Bo, Dong‐Sheng Zhang, Rui-Hua Xu · 发表于：The Lancet Oncology · 年份：2025 · DOI：10.1016/s1470-2045(24)00636-3 · 被引用次数：61 · 研究领域：Barrier Structure and Function Studies、HER2/EGFR in Cancer Research、Cell Adhesion Molecules Research